Login

Financial Snapshot

Revenue
TTM
$108.2M
Gross Margin
TTM
68.96%
Net Income
TTM
-$73.96M
Current Assets
2025 Q3
Current Liabilities
2025 Q3
Current Ratio
2025 Q3
46.95%
Total Assets
2025 Q3
Total Liabilities
2025 Q3
Book Value
2025 Q3
-41.37M
Cash
2025 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$21.00M

Stock Price

Loading...
Market Cap: $31.3 Million

About ARIZONA VENTURES INC

The filing excerpts provided for ZYXIQ do not contain sufficient business description content to construct a SEC-grounded company summary. The 10-K cover page excerpt (filed 2025-03-11, accession 000155837025002717) is missing the registrant name, state of incorporation, IRS EIN, principal office address, fiscal year end date, exchange name, and all substantive business description sections. No information about the company's industry, core business activity, revenue model, products, customers, or competitive position can be extracted from the available text. A canonical description cannot be written without fabricating facts not supported by the filing.

Source: SEC 10-K, filed 2025-03-11

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories Clearpoint Neuro Inc Cue Health Inc. Vicarious Surgical Inc IRadimed Corp Orthofix Medical Inc Sight Sciences Inc Semler Scientific, Inc. SURMODICS INC ZimVie Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support